# data[].attributes.body
Connectedness. I will be able to help my colleagues and patients see the bigger picture, such as how TMS fits into a continuum of care for depression, anxiety, or neurological conditions.

Belief: I will be able to naturally encourage collaboration across disciplines (e.g., psychiatry, neurology, nursing, social work), helping to integrate TMS into patient care workflows.

Learner: I come eager to learn from my team members, on how to integrate this new technology into something meaningful that can help my patients cope with depression.

Adaptability: I can respond well to unexpected challenges during the implementation of TMS and receive positive patient feedback.

Empathy: Dealing with depressed patients requires a lot of patience. I can act as the go-between technology and people, ensuring that innovation does not eclipse humanity

# data[].attributes.body
Sheila will be my project lead. As a strategic leader, she will contribute to guiding the long-term vision for integrating TMS into practice.

Faith is a plus to our team as a futurist, as she will position us at the forefront of next-generation mental health care.

AI is here to stay, and medicine is moving rapidly toward personalized, non-invasive, data-driven, and tech-integrated solutions. TMS is a perfect example of that trajectory.

Emily's empathy will be helpful on my team, as people who are depressed need a lot of love and care. To increase treatment adherence, Emily will help build trust and rapport with patients; she excels at motivating and guiding them through treatment.

Daniel is disciplined and will handle the machine on the patient's forehead. He pays attention to procedure, is keen on safety, and is technically precise.

Randall will be responsible for ensuring the team is FDA compliant, tracking regulatory compliance, and securing reimbursement.

# data[].attributes.wish_content.attachment_props.alternative_text
Depression Treatment: Transcranial Magnetic Stimulation (TMS) | Stanford

# data[].attributes.body
My opinion is that TMS offers an alternative to helping people with depression. In a time when mental health needs are growing and traditional medication doesn’t work for everyone, TMS fills a critical gap in care. It is also a non-invasive procedure requiring no sedation; patients can even drive back to work after their sessions. It is FDA approved, meaning it has evidence-based Effectiveness, which means it can be trusted.

My rationale is that patients have a growing demand for non-pharmacological options. More patients today seek non-drug treatments, especially those wary of long-term medication use. TMS offers an empowering alternative that aligns with patient-centered care.

# data[].attributes.body
It can be costly and may not be covered by all insurance plans.

It requires multiple in-clinic sessions over several weeks.

Additionally, it is not suitable for individuals with certain metal implants or a history of seizures.

TMS requires multiple sessions over several weeks and may not be effective for all patients.

Some individuals may experience mild side effects, such as scalp discomfort or headaches.

# data[].attributes.headline
Embedded Video Explanation of Transcranial Magnetic Stimulation/Stanford University

# data[].attributes.subject
Embedded Video Explanation of Transcranial Magnetic Stimulation/Stanford University

# data[].attributes.body
Low risk of seizures

TMS offers a drug-free alternative with minimal systemic side effects

TMS represents a significant step forward in the treatment of mental health and neurological conditions, especially for patients who have not responded to conventional therapies.

Its continual evolution underscores the potential of neurotechnology in shaping the future of personalized and non-invasive mental health care.

# data[].attributes.body
Transcranial Magnetic Stimulation (TMS) is a cutting-edge, non-invasive brain stimulation technology that has significantly advanced in the past five years. Originally approved for treatment-resistant depression, TMS uses magnetic pulses to stimulate specific areas of the brain involved in mood regulation. Recent innovations, such as intermittent Theta Burst Stimulation (iTBS), have drastically reduced treatment time from over 30 minutes to just 3 minutes per session, improving patient convenience and accessibility.

Since 2020, TMS has gained expanded FDA approvals and clinical use for a variety of mental health conditions, including obsessive-compulsive disorder (OCD), anxiety, and smoking cessation. It is especially promising for patients who do not respond well to medication or prefer non-pharmacologic treatment options. Researchers are also exploring portable and home-based TMS devices, which could revolutionize mental health care access in the near future.

# data[].attributes.attachment_link.title
Depression Treatment: Transcranial Magnetic Stimulation (TMS) | Stanford